HansaBioMed Life Sciences Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
HansaBioMed Life Sciences General Information
Description
Manufacturer of biotechnology products intended for extracellular vesicle and exosome research. The company offers isolation kits, purified vesicles, monoclonal antibodies, and specialized laboratory services, designed for academic and industrial researchers to advance scientific discovery in diagnostics and therapeutics.
Contact Information
Website
www.hansabiomed.eu(Operating Subsidiary)
Corporate Office
- Mäealuse 2/1
- Tallinn, 12618
- Estonia
Corporate Office
- Mäealuse 2/1
- Tallinn, 12618
- Estonia
HansaBioMed Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HansaBioMed Life Sciences Patents
HansaBioMed Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015185730-A2 | Exosomal biomarkers | Inactive | 06-Jun-2014 | ||
| WO-2015185730-A3 | Use of tm9sf4 as a biomarker for tumor associated exosomes | Inactive | 06-Jun-2014 | ||
| EP-2245465-A1 | A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression | Active | 25-Jan-2008 | ||
| EP-2245465-B1 | A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression | Active | 25-Jan-2008 | ||
| WO-2009092385-A1 | A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression | Inactive | 25-Jan-2008 | G01N33/5758 |
HansaBioMed Life Sciences Signals
HansaBioMed Life Sciences Investments (1)
HansaBioMed Life Sciences’s most recent deal was a Later Stage VC with Exosomics. The deal was made on 17-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Exosomics | 17-May-2017 | Later Stage VC | Diagnostic Equipment |
HansaBioMed Life Sciences FAQs
-
When was HansaBioMed Life Sciences founded?
HansaBioMed Life Sciences was founded in 2007.
-
Where is HansaBioMed Life Sciences headquartered?
HansaBioMed Life Sciences is headquartered in Tallinn, Estonia.
-
What is the size of HansaBioMed Life Sciences?
HansaBioMed Life Sciences has 13 total employees.
-
What industry is HansaBioMed Life Sciences in?
HansaBioMed Life Sciences’s primary industry is Biotechnology.
-
Is HansaBioMed Life Sciences a private or public company?
HansaBioMed Life Sciences is a Private company.
-
What is HansaBioMed Life Sciences’s current revenue?
The current revenue for HansaBioMed Life Sciences is .
-
When was HansaBioMed Life Sciences acquired?
HansaBioMed Life Sciences was acquired on 16-May-2017.
-
Who acquired HansaBioMed Life Sciences?
HansaBioMed Life Sciences was acquired by Lonza Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process